Healthcare
Patient Square leads $145m round for Apollo Therapeutics
Biotech company will use the funding to advance its lead therapeutic programmes into clinical development
Five Arrows wins £300m Sygnature Discovery auction
GP will take over Phoenix Equity Partners' minority stake, acquired in 2017
Clessidra holds €270m first close for fourth fund
Clessidra Capital Partners 4 was launched in November 2020 and has a €500m target
Exponent sells BBI Group to Novo Holdings in £400m deal
Exponent acquired the diagnostics products and services business in 2015 for ТЃ75m
VC-backed Biosergen raises €5m via unit offering ahead of IPO
Company will use the proceeds from the offering to launch clinical trials of its antifungal drug candidate
Alto Partners backs Diatech
GP invests in the company via Alto Capital IV, which held a final close on its €210m hard-cap in April 2018
Exponent sells BBI Healthcare to trade
BBI Healthcare is the consumer products division of BBI Group, which the GP has owned since 2015
CapVest gears up for launch of CapVest V
GP backs mid-market companies in essential goods and services; it sold Valeo Foods to Bain for тЌ1.7bn in May 2021
Kempen invests in BCP's Ounda
Beyond Capital Partners formed the optician and audiology chain as a buy-and-build platform in 2020
KKA Partners holds first close for second fund
KKA Value Fund II has a €200m target and has made its first investment, acquiring IT service Xantaro
Kester nets 3.4x return on sale of Frontier Medical to Agilitas
GP's exit comes eight years after it acquired the company via its maiden fund
Palamon takes over Carlyle's IDH stake
Carlyle acquired IDH in 2011; the firm merged with Palamon's ADP and Palamon rolled over its stake
Multiples Heatmap: hectic Q1 further fuels valuation hike
Deal multiples saw four consecutive quarterly increases to reach 11.5x in the first quarter of 2021
Ysios Capital closes third fund on €216m
Fund provides private equity financing to early- and mid-stage life sciences companies
Apposite heads for autumn final close for third fund
Healthcare-focused GP has made its first deal from the fund, acquiring Switzerland-based 1Med
Vectura board greenlights £958m Carlyle offer
Vectura Group is a listed, UK-based developer of inhaled drug delivery devices
Keensight Capital to buy Symeres from Gilde Healthcare
Gilde's exit comes four years after it invested in the drug discovery and medicinal chemistry company
Novo, HBM lead CHF 100m round for Numab
New investors in the round include Forbion, which is participating via its Growth Opportunities fund
Summa Equity to sell HyTest in €545m trade deal
Company in 2019 recorded SEK 299m in revenues and an adjusted EBITDA of тЌ15m
Neuberger exits Service Med to MedicAir
GP sells its 75% stake in the medical company, controlled via Atlante Private Equity Fund
Abénex backs medical imaging software provider EDL
GP plans to support the company in boosting its organic growth and accelerating its expansion through targeted add-ons
Paragon's Apontis Pharma completes IPO
GP acquired the single-pill producer in a carve-out in 2018 and will retain a 31% stake
UI Investissement, Geneo back clinic operator GBNA
UI and Geneo invest in the company via a capital increase, partnering with the Guichard family
Abingworth Clinical Co-Development Fund 2 closes on $582m
ACCD 2 finances the development of late-stage clinical programmes of pharmaceutical and biotechnology companies